MicroRNA in Alzheimer’s disease: an exploratory study in brain, cerebrospinal fluid and plasma

References

• Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. (1997). The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s Disease. Neurobiol Aging 18:S1–2
   Google Scholar
• Abner EL, Kryscio RJ, Schmitt FA, et al. (2011). “End-stage” neurofibrillary tangle pathology in preclinical Alzheimer’s disease: fact or fiction? J Alzheimers Dis 25:445–53
   Google Scholar
• Adilakshmi T, Sudol I, Tapinos N. (2012). Combinatorial action of miRNAs regulates transcriptional and post-transcriptional gene silencing following in vivo PNS injury. PLoS One 7:e39674 (1--14)
   Google Scholar
• Aqeilan RI, Calin GA, Croce CM. (2010). miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ 17:215–20
   PubMed Web of Science ®Google Scholar
• Betel D, Koppal A, Agius P, et al. (2010). Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol 11:R90 (1--14)
   Google Scholar
• Betel D, Wilson M, Gabow A, et al. (2008). The microRNA.org resource: targets and expression. Nucleic Acids Res 36:D149–53
   PubMed Web of Science ®Google Scholar
• Bobinski M, Wegiel J, Tarnawski M, et al. (1997). Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease. J Neuropathol Exp Neurol 56:414–20
   PubMed Web of Science ®Google Scholar
• Boissonneault V, Plante I, Rivest S, Provost P. (2009). MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J Biol Chem 284:1971–81
   PubMed Web of Science ®Google Scholar
• Bonci D, Coppola V, Musumeci M, et al. (2008). The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 14:1271–7
   PubMed Web of Science ®Google Scholar
• Breving K, Esquela-Kerscher A. (2010). The complexities of microRNA regulation: mirandering around the rules. Int J Biochem Cell Biol 42:1316–29
   PubMed Web of Science ®Google Scholar
• Calin GA, Dumitru CD, Shimizu M, et al. (2002). Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99:15524–9
   PubMed Web of Science ®Google Scholar
• Carlsson J, Helenius G, Karlsson M, et al. (2010). Validation of suitable endogenous control genes for expression studies of miRNA in prostate cancer tissues. Cancer Genet Cytogenet 202:71–5
   Google Scholar
• Chang KH, Mestdagh P, Vandesompele J, et al. (2010). MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer 10:173 (1--13)
   Google Scholar
• Chang KW, Chu TH, Gong NR, et al. (2012). miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma. Oral Dis 10:1–9
   Google Scholar
• Cogswell JP, Ward J, Taylor IA, et al. (2008). Identification of miRNA changes in Alzheimer’s disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 14:27–41
   PubMed Web of Science ®Google Scholar
• Das S, Bryan K, Buckley PG, et al. (2013). Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs. Oncogene 32:2927–36
   Google Scholar
• Davoren PA, McNeill RE, Lowery AJ, et al. (2008). Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol 9:76 (1–11)
   Google Scholar
• Delay C, Mandemakers W, Hebert SS. (2012). MicroRNAs in Alzheimer’s disease. Neurobiol Dis 46:285–90
   Web of Science ®Google Scholar
• Edbauer D, Neilson JR, Foster KA, et al. (2010). Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 65:373–84
   PubMed Web of Science ®Google Scholar
• Forlenza OV, Diniz BS, Gattaz WF. (2010). Diagnosis and biomarkers of predementia in Alzheimer’s disease. BMC Med 8:89 (1–14)
   Google Scholar
• Fukutani Y, Kobayashi K, Nakamura I, et al. (1995). Neurons, intracellular and extracellular neurofibrillary tangles in subdivisions of the hippocampal cortex in normal ageing and Alzheimer’s disease. Neurosci Lett 200:57–60
   Google Scholar
• Fuller S, Steele M, Munch G. (2010). Activated astroglia during chronic inflammation in Alzheimer’s disease – do they neglect their neurosupportive roles? Mutat Res 690:40–9
   PubMed Web of Science ®Google Scholar
• Gao W, He HW, Wang ZM, et al. (2012). Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease. Lipids Health Dis 11:55 (1–8)
   Google Scholar
• Garcia-Orti L, Cristobal I, Cirauqui C, et al. (2012). Integration of SNP and mRNA arrays with microRNA profiling reveals that MiR-370 is upregulated and targets NF1 in acute myeloid leukemia. PLoS One 7:e47717 (1–9)
   Google Scholar
• Goldie BJ, Cairns MJ. (2012). Post-transcriptional trafficking and regulation of neuronal gene expression. Mol Neurobiol 45:99–108
   Google Scholar
• Hebert SS, Nelson PT. (2012). Studying microRNAs in the brain: technical lessons learned from the first ten years. Exp Neurol 235:397–401
   Google Scholar
• Humpel C. (2011). Identifying and validating biomarkers for Alzheimer’s disease. Trends Biotechnol 29:26–32
   PubMed Web of Science ®Google Scholar
• Huntzinger E, Izaurralde E. (2011). Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 12:99–110
   PubMed Web of Science ®Google Scholar
• Hyman BT, Phelps CH, Beach TG, et al. (2012). National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimers Dement 8:1–13
   PubMed Web of Science ®Google Scholar
• Iliopoulos D, Drosatos K, Hiyama Y, et al. (2010). MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid Res 51:1513–23
   PubMed Web of Science ®Google Scholar
• Jack CR Jr. (2012). Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play. Radiology 263:344–61
   PubMed Web of Science ®Google Scholar
• John B, Enright AJ, Aravin A, et al. (2004). Human microRNA targets. PLoS Biol 2:e363 (1862–79)
   Google Scholar
• Kawashima H, Numakawa T, Kumamaru E, et al. (2010). Glucocorticoid attenuates brain-derived neurotrophic factor-dependent upregulation of glutamate receptors via the suppression of microRNA-132 expression. Neuroscience 165:1301–11
   PubMed Web of Science ®Google Scholar
• Klein U, Lia M, Crespo M, et al. (2010). The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 17:28–40
   PubMed Web of Science ®Google Scholar
• Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M. (2012). microRNAs in cancer management. Lancet Oncol 13:e249–58
   PubMed Web of Science ®Google Scholar
• Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. (2001). Identification of novel genes coding for small expressed RNAs. Science 294:853–8
   PubMed Web of Science ®Google Scholar
• Lai CP, Breakefield XO. (2012). Role of exosomes/microvesicles in the nervous system and use in emerging therapies. Front Physiol 3:228 (1–14)
   Google Scholar
• Liu DZ, Ander BP, Tian Y, et al. (2012). Integrated analysis of mRNA and microRNA expression in mature neurons, neural progenitor cells and neuroblastoma cells. Gene 495:120–7
   Google Scholar
• Luikart BW, Bensen AL, Washburn EK, et al. (2011). miR-132 mediates the integration of newborn neurons into the adult dentate gyrus. PLoS One 6:e19077 (1–14)
   Google Scholar
• Magill ST, Cambronne XA, Luikart BW, et al. (2010). microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus. Proc Natl Acad Sci U S A 107:20382–7
   PubMed Web of Science ®Google Scholar
• Malumbres M. (2013). miRNAs and cancer: an epigenetics view. Mol Aspects Med 34:863–74
   PubMed Web of Science ®Google Scholar
• McKhann G, Drachman D, Folstein M, et al. (1984). Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34:939–44
   PubMed Web of Science ®Google Scholar
• Mehler MF, Mattick JS. (2006). Non-coding RNAs in the nervous system. J Physiol 575:333–41
   PubMed Web of Science ®Google Scholar
• Mirra SS, Heyman A, McKeel D, et al. (1991). The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–86
   Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, et al. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105:10513–18
   PubMed Web of Science ®Google Scholar
• Mortensen RD, Serra M, Steitz JA, Vasudevan S. (2011). Posttranscriptional activation of gene expression in Xenopus laevis oocytes by microRNA-protein complexes (microRNPs). Proc Natl Acad Sci USA 108:8281–6
   PubMed Web of Science ®Google Scholar
• Mraz M, Malinova K, Mayer J, Pospisilova S. (2009). MicroRNA isolation and stability in stored RNA samples. Biochem Biophys Res Commun 390:1–4
   PubMed Web of Science ®Google Scholar
• Mulder C, Verwey NA, van der Flier WM, et al. (2010). Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. Clin Chem 56:248–53
   PubMed Web of Science ®Google Scholar
• Nelson PT, Wang WX, Rajeev BW. (2008a). MicroRNAs (miRNAs) in neurodegenerative diseases. Brain Pathol 18:130–8
   PubMed Web of Science ®Google Scholar
• Nelson PT, Wang WX, Wilfred BR, Tang G. (2008b). Technical variables in high-throughput miRNA expression profiling: much work remains to be done. Biochim Biophys Acta 1779:758–65
   PubMed Web of Science ®Google Scholar
• Nudelman AS, DiRocco DP, Lambert TJ, et al. (2010). Neuronal activity rapidly induces transcription of the CREB-regulated microRNA-132, in vivo. Hippocampus 20:492–8
   PubMed Web of Science ®Google Scholar
• Nunez-Iglesias J, Liu CC, Morgan TE, et al. (2010). Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer’s disease cortex reveals altered miRNA regulation. PLoS One 5:e8898 (1–9)
   Google Scholar
• Olde Loohuis NF, Kos A, Martens GJ, et al. (2012). MicroRNA networks direct neuronal development and plasticity. Cell Mol Life Sci 69:89–102
   Google Scholar
• Pathania M, Torres-Reveron J, Yan L, et al. (2012). miR-132 Enhances dendritic morphogenesis, spine density, synaptic integration, and survival of newborn olfactory bulb neurons. PLoS One 7:e38174 (1–10)
   Google Scholar
• Peskind ER, Riekse R, Quinn JF, et al. (2005). Safety and acceptability of the research lumbar puncture. Alzheimer Dis Assoc Disord 19:220–5
   PubMed Web of Science ®Google Scholar
• Peskind ER, Li G, Shofer J, et al. (2006). Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition. Arch Neurol 63:936–9
   PubMedGoogle Scholar
• Remenyi J, Hunter CJ, Cole C, et al. (2010). Regulation of the miR-212/132 locus by MSK1 and CREB in response to neurotrophins. Biochem J 428:281–91
   PubMed Web of Science ®Google Scholar
• Rossler M, Zarski R, Bohl J, Ohm TG. (2002). Stage-dependent and sector-specific neuronal loss in hippocampus during Alzheimer’s disease. Acta Neuropathol 103:363–9
   PubMedGoogle Scholar
• Sato F, Tsuchiya S, Terasawa K, Tsujimoto G. (2009). Intra-platform repeatability and inter-platform comparability of microRNA microarray technology. PLoS One 4:e5540 (1–12)
   Google Scholar
• Schipper HM, Maes OC, Chertkow HM, Wang E. (2007). MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regul Syst Bio 1:263–74
   PubMedGoogle Scholar
• Schneider JA, Arvanitakis Z, Bang W, Bennett DA. (2007). Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69:2197–204
   PubMed Web of Science ®Google Scholar
• Sethi P, Lukiw WJ. (2009). Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer’s disease temporal lobe neocortex. Neurosci Lett 459:100–4
   PubMed Web of Science ®Google Scholar
• Shaltiel G, Hanan M, Wolf Y, et al. (2012). Hippocampal microRNA-132 mediates stress-inducible cognitive deficits through its acetylcholinesterase target. Brain Struct Funct 218:59–72
   Google Scholar
• Siegel G, Obernosterer G, Fiore R, et al. (2009). A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nat Cell Biol 11:705–16
   PubMed Web of Science ®Google Scholar
• Smith-Vikos T, Slack FJ. (2012). MicroRNAs and their roles in aging. J Cell Sci 125:7–17
   PubMed Web of Science ®Google Scholar
• Smith PY, Delay C, Girard J, et al. (2011). MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy. Hum Mol Genet 20:4016–24
   Google Scholar
• Sonnen JA, Larson EB, Crane PK, et al. (2007). Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 62:406–13
   PubMed Web of Science ®Google Scholar
• Srikantan S, Marasa BS, Becker KG, et al. (2011). Paradoxical microRNAs: individual gene repressors, global translation enhancers. Cell Cycle 10:751–9
   PubMed Web of Science ®Google Scholar
• Trojanowski JQ, Vandeerstichele H, Korecka M, et al. (2010). Update on the biomarker core of the Alzheimer’s Disease Neuroimaging Initiative subjects. Alzheimers Dement 6:230–8
   PubMedGoogle Scholar
• van Harten AC, Kester MI, Visser PJ, et al. (2011). Tau and p-tau as CSF biomarkers in dementia: a meta-analysis. Clin Chem Lab Med 49:353–66
   PubMed Web of Science ®Google Scholar
• Wang WX, Huang Q, Hu Y, et al. (2011). Patterns of microRNA expression in normal and early Alzheimer’s disease human temporal cortex: white matter versus gray matter. Acta Neuropathol 121:193–205
   PubMed Web of Science ®Google Scholar
• Weber JA, Baxter DH, Zhang S, et al. (2010). The microRNA spectrum in 12 body fluids. Clin Chem 56:1733–41
   PubMed Web of Science ®Google Scholar
• West MJ, Kawas CH, Stewart WF, et al. (2004). Hippocampal neurons in pre-clinical Alzheimer’s disease. Neurobiol Aging 25:1205–12
   PubMed Web of Science ®Google Scholar
• Wharton SB, O’Callaghan JP, Savva GM, et al. (2009). Population variation in glial fibrillary acidic protein levels in brain ageing: relationship to Alzheimer-type pathology and dementia. Dement Geriatr Cogn Disord 27:465–73
   Google Scholar
• White L, Small BJ, Petrovitch H, et al. (2005). Recent clinical-pathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study. J Geriatr Psychiatry Neurol 18:224–7
   PubMed Web of Science ®Google Scholar
• Wu Z, Sun H, Zeng W, et al. (2012). Upregulation of mircoRNA-370 induces proliferation in human prostate cancer cells by downregulating the transcription factor FOXO1. PLoS One 7:e45825 (1–11)
   Google Scholar
• Zen K, Zhang CY. (2012). Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev 32:326–48
   PubMed Web of Science ®Google Scholar
• Zhao BJ, Sun DG, Zhang M, et al. (2009). Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma. Dis Esophagus 22:55–61
   Google Scholar
• Zhu H, Fan GC. (2011). Extracellular/circulating microRNAs and their potential role in cardiovascular disease. Am J Cardiovasc Dis 1:138–49
   PubMedGoogle Scholar